about
Exogenous L-arginine ameliorates angiotensin II-induced hypertension and renal damage in ratsEffects of indomethacin on responses of regional kidney perfusion to vasoactive agents in rabbits.Modulation of V1-receptor-mediated renal vasoconstriction by epoxyeicosatrienoic acids.Angiotensin II and nitric oxide in neural control of intrarenal blood flow.Renal oxygenation in acute renal ischemia-reperfusion injury.Augmented Endothelial-Specific L-Arginine Transport Blunts the Contribution of the Sympathetic Nervous System to Obesity Induced Hypertension in MiceHigh-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice.Corrigendum: N-terminal domain of Bothrops asper Myotoxin II Enhances the Activity of Endothelin Converting Enzyme-1 and Neprilysin.Canopy Venom: Proteomic Comparison among New World Arboreal Pit-Viper Venoms.Role of L-arginine in nitric oxide production in health and hypertension.The Cardiovascular and Neurotoxic Effects of the Venoms of Six Bony and Cartilaginous Fish Species.Endothelin-converting enzyme-1 inhibition and renoprotection in end-stage renal disease.Pathogenesis and treatment of the cardiorenal syndrome: Implications of L-arginine-nitric oxide pathway impairment.Say NO to Obesity-Related Hypertension: Role of the L-Arginine-Nitric Oxide Pathway.Role of Renal Oxidative Stress in the Pathogenesis of the Cardiorenal Syndrome.Nitric oxide inhibits the production of soluble endothelin converting enzyme-1.Production of soluble Neprilysin by endothelial cells.Effects of Dietary l-Arginine on Nitric Oxide Bioavailability in Obese Normotensive and Obese Hypertensive Subjects.N-acetylcysteine attenuates the development of cardiac fibrosis and remodeling in a mouse model of heart failure.Augmented endothelial l-arginine transport ameliorates pressure-overload-induced cardiac hypertrophy.Pharmacological hypothesis: Nitric oxide-induced inhibition of ADAM-17 activity as well as vesicle release can in turn prevent the production of soluble endothelin-converting enzyme.Augmented endothelial-specific L-arginine transport prevents obesity-induced hypertension.Cardio-protective effects of combined l-arginine and insulin: Mechanism and therapeutic actions in myocardial ischemia-reperfusion injury.N-Acetylcysteine Attenuates the Development of Renal Fibrosis in Transgenic Mice with Dilated Cardiomyopathy.Stimulating the Activity of Amyloid-Beta Degrading Enzymes: A Novel Approach for the Therapeutic Manipulation of Amyloid-Beta Levels.Letter by Rajapakse et al Regarding Article, "Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition".Serelaxin attenuates renal inflammation and fibrosis in a mouse model of dilated cardiomyopathyANG II type 2 receptors and neural control of intrarenal blood flowEndothelial cationic amino acid transporter-1 overexpression can prevent oxidative stress and increases in arterial pressure in response to superoxide dismutase inhibition in miceEndothelial cationic amino acid transporter-1 overexpression blunts the effects of oxidative stress on pressor responses to behavioural stress in mice
P50
Q24646456-9945995D-49D9-475D-A1C3-A90D8B6888BEQ31107157-8F308D28-81E2-4620-8C8F-2CFE820F0438Q33198706-6EC9110D-52C2-4E5E-BE07-7987A7A373C9Q33214987-DDAD4D2F-782C-48F2-B0CD-AAF76B06F94AQ35112037-27293BE9-67AD-4F20-8A2F-42168F880C1CQ35695167-9DD6AC6D-AC88-4C0C-9EEB-BC346A5C9713Q36215430-7AF001E4-57C1-4F5A-A676-576DB6CB6FDAQ36824107-79C39B1E-9B72-4C17-AC2E-9CB6F0414920Q37132924-0A8B8F83-239E-4C2B-BE25-B604D36E815CQ37348354-FCF23583-DFEB-4E62-89E9-80B31A6EF084Q37673002-825817D9-90D5-4F36-8B76-70A68796D039Q38074820-493718B0-3092-4E3D-97ED-F6BF4D9BC3B9Q38491391-DDF9380B-195A-48D6-9558-5F841AD5DA4EQ38791591-6F8221F3-B596-441B-AF29-48767259F991Q38822122-460993BD-A73A-43E5-8522-63B472BE249AQ38956067-4182DAFD-C468-4867-9207-82466F2C90D7Q39027336-6B5A2038-F60D-4E7E-B2B5-A0105C6762F7Q39675668-AEC39464-DD9F-48BF-95B2-FDE261601AD4Q39849083-CBEA649B-D3AD-418A-A8C3-67D8BD2DDB36Q40956179-ED927D20-B490-425B-A2F8-5A26CFB1D01EQ42285713-7C4C23EE-CF97-4461-99C8-54E19D427F27Q44178718-6133C897-E3C8-4EFF-AF18-1E74836C1793Q46645511-06311B6F-E63D-4CCE-A666-064F5D7EE1A6Q47156134-88150D0E-A137-41CA-906D-25BDD2D7A497Q48547451-95D0AF6F-2D2B-47B5-9F71-BEBEF779ACD2Q51629569-B7BDA9A8-54C9-47B9-B2B6-FC6914B9F485Q57470967-564A100B-9865-422C-963A-140FD75D8CB0Q79954884-FAD4F9E3-8FD7-44BA-A78F-4D90D506D30EQ87104761-78C2B492-3CA5-43C6-A2E2-473904800C38Q87554635-B02B9A86-3EC3-4AFC-81E6-9FECC70879FC
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Niwanthi W Rajapakse
@ast
Niwanthi W Rajapakse
@en
Niwanthi W Rajapakse
@es
Niwanthi W Rajapakse
@nl
type
label
Niwanthi W Rajapakse
@ast
Niwanthi W Rajapakse
@en
Niwanthi W Rajapakse
@es
Niwanthi W Rajapakse
@nl
prefLabel
Niwanthi W Rajapakse
@ast
Niwanthi W Rajapakse
@en
Niwanthi W Rajapakse
@es
Niwanthi W Rajapakse
@nl
P106
P1153
7004066533
P31
P496
0000-0001-9777-1087